𝔖 Bobbio Scriptorium
✦   LIBER   ✦

2.265 LONG-TERM SAFETY AND SUSTAINED EFFICACY OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY AND ADVANCED PARKINSON'S DISEASE

✍ Scribed by W. Poewe; P. Barone; R. Hauser; Y. Mizuno; O. Rascol; M. Busse; C. Debieuvre; M. Fraessdorf; A. Schapira

Book ID
117754958
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
76 KB
Volume
18
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy and safety of pramipe
Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: Results from a European multicenter trial
✍ J. Carsten Möller; Wolfgang H. Oertel; Jürgen Köster; Gianni Pezzoli; Leandro Pr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

## Abstract A double‐blind, placebo‐controlled study with a subsequent open‐label phase was conducted in 354 patients with Parkinson's disease (PD) and motor fluctuations under individually adjusted therapy with levodopa. During the double‐blind phase 174 patients received pramipexole and 180 place

Efficacy, safety, and tolerability of ov
Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease
✍ Olivier Rascol; Paolo Barone; Robert A. Hauser; Yoshikuni Mizuno; Werner Poewe; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Abstract The aim of this article is to test the feasibility, in early Parkinson's disease (PD), of an overnight switch from immediate‐release (IR) pramipexole to a new once‐daily extended‐release (ER) formulation. Nonfluctuating patients on pramipexole IR three‐times daily, alone or with levodop